AbCellera Biologics Inc. (ABCL) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.49 | +10.9% |
| 2024 | $-0.55 | -7.8% |
| 2023 | $-0.51 | -202.0% |
| 2022 | $0.50 | +4.2% |
| 2021 | $0.48 | +6.7% |
| 2020 | $0.45 | +4600.0% |
| 2019 | $-0.01 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.49 | +10.9% |
| 2024 | $-0.55 | -7.8% |
| 2023 | $-0.51 | -202.0% |
| 2022 | $0.50 | +4.2% |
| 2021 | $0.48 | +6.7% |
| 2020 | $0.45 | +4600.0% |
| 2019 | $-0.01 | — |